Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Insect Venom Allergenic Extract [EPC]
Northern Quahog is a specialized allergenic extract used in the diagnosis and treatment of shellfish allergies. It belongs to the class of non-standardized food allergenic extracts and is administered under strict medical supervision.
Name
Northern Quahog
Raw Name
NORTHERN QUAHOG
Category
Standardized Insect Venom Allergenic Extract [EPC]
Drug Count
3
Variant Count
3
Last Verified
February 17, 2026
About Northern Quahog
Northern Quahog is a specialized allergenic extract used in the diagnosis and treatment of shellfish allergies. It belongs to the class of non-standardized food allergenic extracts and is administered under strict medical supervision.
Detailed information about Northern Quahog
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Northern Quahog.
Northern Quahog (scientific name: Mercenaria mercenaria) is a clinical allergenic extract derived from the hard-shell clam. In the realm of clinical pharmacology, it is classified primarily as a Non-Standardized Food Allergenic Extract [EPC], though it may also be categorized under Standardized Insect Venom Allergenic Extract [EPC] or Non-Standardized Plant Allergenic Extract [EPC] in specific multi-antigen formulations. According to the FDA’s Center for Biologics Evaluation and Research (CBER), these extracts are biological products intended for use in the diagnosis of IgE-mediated (Type I) allergies and for the practice of allergen immunotherapy (hyposensitization).
Northern Quahog extracts are prepared by extracting the water-soluble proteins from the raw or processed tissues of the clam. The resulting solution contains a complex mixture of proteins, glycoproteins, and polysaccharides. The most significant allergen identified in Northern Quahog is tropomyosin, a muscle protein that is highly conserved across various shellfish species. Healthcare providers utilize this extract to confirm whether a patient has a specific sensitivity to Northern Quahog, which is a common cause of food-induced allergic reactions, including urticaria (hives), angioedema (swelling), and life-threatening anaphylaxis.
The therapeutic and diagnostic mechanism of Northern Quahog extract is centered on the human immune system's recognition of specific allergens. When used for diagnostic purposes (such as skin prick testing), the extract is introduced into the epidermis. If the patient is sensitized, IgE antibodies bound to mast cells recognize the Northern Quahog proteins, causing the mast cells to degranulate and release inflammatory mediators like histamine. This results in a localized 'wheal and flare' reaction (a raised bump and surrounding redness).
When used for immunotherapy, the mechanism is more complex. By administering gradually increasing doses of the Northern Quahog extract via subcutaneous (under the skin) injection, the immune system undergoes a shift. This process, known as desensitization, involves the induction of T-regulatory cells and the production of 'blocking' antibodies, specifically IgG4. These IgG4 antibodies compete with IgE for the allergen, effectively preventing the mast cell activation that leads to allergic symptoms. Over time, this can significantly increase the patient's threshold for allergic reactions upon accidental exposure to the shellfish.
Traditional pharmacokinetic parameters—such as bioavailability, half-life, and metabolism—are not typically measured for allergenic extracts like Northern Quahog in the same way they are for synthetic drugs. This is because the extract is a biological mixture that acts locally and is processed by the immune system.
Northern Quahog allergenic extract is FDA-approved for the following clinical indications:
Off-label uses are rare, though some researchers investigate the use of these extracts in oral immunotherapy (OIT) protocols, which must only be performed in highly specialized clinical trial settings.
Northern Quahog extract is typically available in the following forms:
> Important: Only your healthcare provider can determine if Northern Quahog extract is right for your specific diagnostic or therapeutic needs. The administration must occur in a facility equipped to handle severe allergic reactions.
Dosage for Northern Quahog allergenic extract is highly individualized and must be determined by an allergist based on the patient's sensitivity levels. There is no 'standard' dose that applies to all patients.
For Skin Prick Testing (SPT), a single drop of the extract (typically 1:10 or 1:20 w/v) is applied to the skin, and a sterile lancet is used to prick the epidermis. The results are read after 15 to 20 minutes.
Immunotherapy involves two distinct phases:
Northern Quahog extract can be used in children, but the dosage must be adjusted based on the child's size and the severity of their allergy. Pediatric patients are at a higher risk for systemic reactions, and therefore, the build-up phase may be more conservative. Clinical studies suggest that immunotherapy is most effective when started in children who have persistent symptoms despite allergen avoidance.
No specific dosage adjustments are required for patients with renal impairment, as the systemic protein load is minimal. However, healthcare providers should monitor these patients closely for any unusual systemic responses.
Similar to renal impairment, hepatic dysfunction does not typically require a dose change, but the patient's overall health and ability to tolerate a systemic reaction must be considered.
Elderly patients may have a higher risk of cardiovascular complications if a systemic reaction occurs. Dosage should be approached with caution, starting at the lowest possible concentration.
Northern Quahog extract is never self-administered by the patient at home. It must be administered by a trained healthcare professional in a clinical setting.
If an immunotherapy dose is missed, the next dose may need to be reduced depending on how much time has passed.
An 'overdose' in the context of allergenic extracts refers to the administration of a dose that exceeds the patient's current tolerance level. This can lead to a severe systemic reaction or anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not attempt to alter your injection schedule without professional medical guidance.
Most patients receiving Northern Quahog extracts will experience some form of localized reaction. These are generally not dangerous but can be uncomfortable.
> Warning: Stop the administration process and call for emergency help immediately if you experience any of the following symptoms of anaphylaxis:
There are no known long-term 'toxic' effects of Northern Quahog extract, as it is a natural protein. However, the primary long-term risk is the development of a 'new' sensitivity or the worsening of asthma if the immunotherapy is not managed correctly. Long-term use is generally intended to induce tolerance, which is a beneficial effect.
While Northern Quahog extract itself may not always carry a specific black box warning on every manufacturer's label, the class of Allergenic Extracts frequently carries a boxed warning regarding Anaphylaxis.
FDA Boxed Warning Summary:
Report any unusual symptoms, even if they seem minor, to your healthcare provider immediately after receiving an injection.
Northern Quahog allergenic extract is a potent biological substance. It is only intended for use by specialists in allergy and immunology. Patients must be fully informed of the risks of systemic reactions before beginning a course of diagnostic testing or immunotherapy.
No FDA black box warnings are specific to the 'Northern Quahog' name alone in some databases, but as a member of the Allergenic Extracts class, it is subject to the general class warning for Anaphylaxis. This warning emphasizes that the product can cause fatal reactions and must be used with extreme caution in patients with respiratory compromise.
Patients should avoid driving or operating heavy machinery immediately after an injection if they feel dizzy, fatigued, or if they have experienced a systemic reaction. However, for most patients, the extract does not interfere with these activities once the 30-minute observation period has passed without incident.
Alcohol should be avoided on the day of an immunotherapy injection. Alcohol can cause vasodilation (widening of blood vessels), which may increase the rate of allergen absorption and potentially increase the risk or severity of a systemic reaction.
If a patient experiences a severe systemic reaction, the healthcare provider may decide to discontinue Northern Quahog immunotherapy entirely. There is no 'withdrawal syndrome' associated with stopping allergenic extracts, but the patient's allergy symptoms will likely return to their baseline levels over time.
> Important: Discuss all your medical conditions, especially respiratory and heart issues, with your healthcare provider before starting Northern Quahog.
While there are few absolute contraindications for drug combinations, the following are generally avoided during Northern Quahog administration:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure or heart rhythm.
Northern Quahog extract must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients with a known allergy to other mollusks (scallops, oysters, mussels) or crustaceans (shrimp, lobster) are likely to be cross-sensitive to Northern Quahog. This is due to the presence of the pan-allergen tropomyosin. Healthcare providers must be aware that a patient sensitized to one shellfish may react more strongly to the Northern Quahog extract than expected.
> Important: Your healthcare provider will evaluate your complete medical history and current respiratory health before prescribing or administering Northern Quahog extract.
Northern Quahog extract is generally classified as Pregnancy Category C. This means that animal reproduction studies have not been conducted, and it is not known if the extract can cause fetal harm.
It is not known whether Northern Quahog allergenic proteins are excreted in human milk. Because these are large proteins that are likely digested in the infant's gut, the risk to a nursing infant is considered very low. However, the decision to continue immunotherapy while breastfeeding should be made after discussing the risks and benefits with a physician.
Northern Quahog extract is used in the pediatric population for both diagnosis and treatment.
Patients over the age of 65 require special consideration.
There are no specific guidelines for Northern Quahog use in renal impairment. However, since the proteins are eventually cleared by the kidneys, patients with end-stage renal disease should be monitored for any signs of protein accumulation or unusual sensitivity.
No dosage adjustments are provided for patients with liver disease. The metabolic processing of these proteins is primarily proteolytic and does not rely heavily on the cytochrome P450 system of the liver.
> Important: Special populations, particularly pregnant women and the elderly, require a highly individualized medical assessment before receiving allergenic extracts.
Northern Quahog allergenic extract works through the modulation of the Type I hypersensitivity pathway.
| Parameter | Value |
|---|---|
| Bioavailability | Low (Subcutaneous/Local) |
| Protein Binding | N/A (Biological Protein) |
| Half-life | Minutes to Hours (Proteins) |
| Tmax | 15-30 minutes (Local absorption) |
| Metabolism | Tissue Proteases |
| Excretion | Renal/Hepatic (Peptides) |
Northern Quahog belongs to the Allergenic Extracts therapeutic class. It is specifically a Non-Standardized Food Allergenic Extract. Other drugs in this class include extracts for shrimp, crab, codfish, and various pollens or molds.
Medications containing this ingredient
Common questions about Northern Quahog
Northern Quahog allergenic extract is primarily used by allergists to diagnose and treat shellfish allergies. In a diagnostic setting, it is used in skin prick tests to see if a patient has an immediate allergic reaction to the clam proteins. For treatment, it is used in allergen immunotherapy, where small, increasing doses are injected to help the body build a tolerance. This is especially helpful for patients who have severe reactions and may be at risk of accidental exposure. It is not a medication used to treat an active allergic reaction but rather a tool for long-term management.
The most common side effects are localized to the site where the extract was applied or injected. These include redness, itching, and a raised bump known as a wheal, which usually appears within minutes. Some patients may also experience a 'large local reaction' where the swelling spreads several inches across the arm and lasts for a day or two. These local symptoms are generally considered a normal part of the body's response to the allergen. However, any reaction that spreads beyond the injection site should be reported to a doctor immediately.
It is generally advised to avoid alcohol on the days you receive a Northern Quahog injection. Alcohol can cause your blood vessels to dilate, which might speed up the absorption of the allergen into your bloodstream. This increased absorption can raise the risk of a systemic or 'whole-body' allergic reaction. Furthermore, alcohol can sometimes mask the early symptoms of an allergic reaction, making it harder for you or your doctor to identify a problem. Always follow the specific lifestyle restrictions provided by your allergy clinic.
The safety of starting Northern Quahog immunotherapy during pregnancy has not been established, and it is usually avoided. The main risk is not the extract itself but the potential for the mother to have a severe allergic reaction (anaphylaxis), which could deprive the baby of oxygen. However, if a woman is already on a stable maintenance dose of immunotherapy and becomes pregnant, many doctors will choose to continue the treatment. This is because the risk of a reaction is much lower once the body has already become accustomed to the maintenance dose. You must discuss your pregnancy status with your allergist before every injection.
For diagnostic purposes, Northern Quahog extract works almost immediately, with results appearing within 15 to 20 minutes of a skin test. However, for immunotherapy (the treatment to reduce allergy severity), it takes much longer to see results. Most patients begin to notice a decrease in their sensitivity after 6 to 12 months of consistent injections. A full course of treatment typically lasts between 3 and 5 years to ensure long-lasting protection. It is a long-term commitment rather than a quick fix for allergies.
Yes, you can stop receiving Northern Quahog injections at any time without experiencing withdrawal symptoms like those seen with some other medications. However, if you stop the treatment before the recommended 3-to-5-year course is finished, your allergy symptoms are likely to return to their original severity. If you miss just one or two doses, your doctor may simply adjust your next dose rather than stopping the treatment. Always consult your allergist before deciding to discontinue your immunotherapy schedule to understand the impact on your allergy management.
If you miss an immunotherapy appointment, you should contact your allergist's office as soon as possible to reschedule. Missing a dose can affect your level of tolerance, so your doctor may need to reduce the dose of your next injection to ensure safety. The longer the gap between injections, the more the dose may need to be lowered. In some cases, if too many weeks have passed, you may need to go back several steps in your build-up schedule. Do not attempt to 'double up' on doses to make up for a missed one.
There is no clinical evidence to suggest that Northern Quahog allergenic extract causes weight gain. The extract consists of natural proteins and a small amount of glycerin or saline, which do not have metabolic or caloric effects on the body. Unlike some other treatments for allergic conditions, such as oral corticosteroids (like prednisone), allergenic extracts do not affect appetite or fat distribution. If you notice unexpected weight changes while on immunotherapy, you should discuss them with your primary care physician to find the underlying cause.
Northern Quahog can be used alongside many medications, but some require extreme caution. Most importantly, beta-blockers used for heart disease or high blood pressure can make allergic reactions more dangerous and harder to treat. Antihistamines must be stopped before diagnostic skin testing because they will prevent the test from working. You should provide your allergist with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you take. This allows them to safely manage your immunotherapy and ensure that any emergency treatments would be effective if needed.
Northern Quahog extract is a biological product, and the concept of 'generic' vs. 'brand name' works differently than it does for pills. Various laboratories produce Northern Quahog extracts, and while they all contain the same basic clam proteins, they are not always identical in concentration or purity. These are often referred to as 'non-standardized' extracts. Because of these differences, you should ideally stay with the same manufacturer's product throughout your treatment. If your doctor switches brands, they may need to adjust your dose slightly to ensure you tolerate the new formulation safely.